Structure‐Activity Relationship Studies of CNS Agents, XV: N‐[ω‐(4‐Aryl‐1‐piperazinyl)alkyl]‐2‐oxo‐1,2,3,4‐tetrahydroquinolines and ‐4‐oxo‐1,2,3,4‐tetrahydropyrazino[1,2‐a]indoles: New, Highly Potent 5‐HT1A Ligands ωN‐[ω‐(4‐Aryl‐1‐piperazinyl)alkyl]‐2‐oxo‐1,2,3,4‐tetrahydrochinoline und ‐4‐oxo‐1,2,3